HOUSE PANEL SEEKS DATA ON CHIRON INSPECTION

Drug GMP Report
A A

Two influential House lawmakers are seeking documents from the FDA to help shed light on whether the agency knew about problems at vaccine maker Chiron's manufacturing facility in England, which was forced to suspend production of the Fluvirin flu vaccine by UK health regulators.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $10.00